Oral Oxybutynin

DRUG4 trials

Sponsors

University of California, Davis, Samantha Rodrigues Camargo Neves de Moura, Dr. Lutfi Kirdar Kartal Training and Research Hospital, Mansoura university faculty of medicine

Conditions

Anticholinergic Side EffectsAutonomic AgentsChildren and Adolescents, Boys and GirlsCholinergic AntagonistsDrug Delivery SystemsHyperhidrosisNeuropathic BladderOveractive Bladder (OAB)

Phase 2

Topical Oxybutynin for Treatment of Hyperidrosis: Local or Systemic Effect?

RecruitingNCT05102396

Samantha Rodrigues Camargo Neves de MouraAutonomic Agents, Cholinergic Antagonists, Hyperhidrosis +4

Start: 2022-09-26End: 2024-08-30Target: 17Updated: 2024-05-28

Phase 3

Oxybutynin for Post-surgical Bladder Pain and Urgency

RecruitingNCT03952299

University of California, DavisNeuropathic Bladder, Overactive Bladder Syndrome

Start: 2021-09-01End: 2026-12-31Target: 100Updated: 2026-01-29

Unknown Phase

Treatment of primary palmar hyperhidrosis

Active, not recruitingPACTR202006915898923

Mansoura university faculty of medicineSkin and Connective Tissue Diseases

Start: 2020-05-15Target: 80Updated: 2026-09-14

Transdermal Versus Oral Oxybutynin in Pediatric OAB

CompletedNCT07081906

Dr. Lutfi Kirdar Kartal Training and Research HospitalAnticholinergic Side Effects, Children and Adolescents, Boys and Girls, Drug Delivery Systems +1

Start: 2019-02-15End: 2020-05-01Updated: 2025-07-23